The weekly litigation news digest is live. Subscribe now

Pinsent Masons patent opposition analysis

The comprehensive analysis of Pinsent Masons opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Pinsent Masons

Patent NumberTitleApplicantOpposition DateOpposition Company
Uses For And Article Of Manufacture Including Her2 Dimerization Inhibitor PertuzumabF HOFFMANN LA ROCHEOct 28, 2025LANYON OPPOSITIONS
New Use Of A Combination Of An Angiotensin Receptor Blocker (Arb) With A Neutral Endopeptidase Inhibitor (Nepi)NOVARTISJul 23, 2025LANYON OPPOSITIONS
High-Purity Peg Lipids And Uses ThereofMODERNAJul 2, 2025LANYON OPPOSITIONS
Uses For And Article Of Manufacture Including Her2 Dimerization Inhibitor PertuzumabF HOFFMANN LA ROCHEJun 17, 2025LANYON OPPOSITIONS
Adjuvant Treatment Of Her2-Positive Breast CancerF HOFFMANN LA ROCHEJul 31, 2024LANYON OPPOSITIONS
Methods For Treating Or Preventing Asthma By Administering An Il-4R AntagonistREGENERON PHARMACEUTICALSJul 30, 2024LANYON OPPOSITIONS
New UseNOVARTISJul 11, 2024LANYON OPPOSITIONS
Sacubitril-Valsartan Dosage Regimen For Treating Heart FailureNOVARTISDec 7, 2023STRAWMAN
Prevention Of Disulfide Bond Reduction During Recombinant Production Of PolypeptidesGENENTECHNov 29, 2023STRAWMAN

Top companies who are the clients of Pinsent Masons